排序方式: 共有7条查询结果,搜索用时 15 毫秒
1
1.
2.
INTRODUCTIONAPSisthesumtotalthatcoversaseriesofclinicalmanifestations,causedbyantiphospho lipidantibodies (APL)associatedwithhabitualabortionorintrauterinefetaldeath ,arterialandvenousthrombus,thrombocytopeniaandhemo lyticanemia.APL ,acomplement fixingant… 相似文献
3.
目的:观察复方血栓通软胶囊联合阿托伐他汀钙片治疗老年高脂血症的临床疗效。方法:将64例符合纳入标准的高脂血症患者随机分为对照组和观察组,对照组应用阿托伐他汀钙片治疗,观察组应用复方血栓通软胶囊联合阿托伐他汀钙片治疗,两组治疗前后进行疗效比较。结果:治疗后观察组与对照组比较,血清总胆固醇、甘油三脂、低密度脂蛋白明显降低,高密度脂蛋白明显升高,差异均具有统计学意义(P0.05);观察组总有效率为,对照组总有效率为,两组比较差异有统计学意义(P0.05)。结论:复方血栓通软胶囊联合阿托伐他汀钙片治疗老年高脂血症能够迅速降低总胆固醇、甘油三脂、低密度脂蛋白,具有较好的临床疗效,值得广泛推广。 相似文献
4.
按凝血过程激发、放大、凝血酶和纤维蛋白形成的顺序,从原理、临床试验、到作为抗栓塞新药应用对目前国内外抗凝血药物的研究进行了详细评述. 相似文献
5.
Sakshi Batra Asha G Nair Kirtimaan Syal 《Indian journal of clinical biochemistry : IJCB》2023,38(2):275
SARS-CoV-2, an etiological agent of COVID-19, has been reported to inflict remarkably diverse manifestations in different subjects across the globe. Though patients with COVID-19 predominantly have fever, respiratory and constitutional symptoms, atypical presentations are becoming increasingly evident.COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilization, and diffuse intravascular coagulation in moderate to severe symptomatic cases. In this case report, we are reporting thromboembolic complications of COVID-19 in a mild symptomatic subject incidentally diagnosed with mesenteric venous occlusion with no abdominal symptoms.Early recognition of the abdominal symptoms, diagnosis, initiation of anticoagulants, and timely surgical intervention may improvise the outcome in a patient with COVID-19 infection-induced mesenteric thrombosis. Superior mesenteric artery and venous thrombosis may lead to subsequent ischemia necessitating emergency laparotomy. Thus, the usage of low-dose anticoagulants in all the patients of COVID-19 irrespective of the categorization into mild, moderate, and severe COVID-19 disease should be considered. 相似文献
6.
Objective: To gain further understanding of the antiphospholipid syndrome (APS). Methods: Analysing clinical and laboratory
data on ten cases of APS. Results: Thrombocytopenia appeared in all cases. Venous thrombi of limbs appeared in five cases
and neurological abnormalities in two cases. Renal impairments were found in three cases. One case manifested left renal venous
thrombi and the other two cases thrombotic microangiopathy. Budd-Chiari syndrome was found in one case. One of the ten cases
was catastrophic APS (CAPS) presented as acute diffuse swelling, cyanosis, pain, ischemia and necrosis in fingers and limbs,
recurrent shock, ascites, hepatic and respiratory dysfunction. Anticoagulants and corticosteroids could be effective foctive
for dealing with APS. It was critical to treat catastrophic APS with anticoagulants or plasmapheresis as early as possible.
Conclusion: APS shows variable manifestations for good prognosis, but catastrophic APS has fatal risk. The main treatment
for APS is the use of anticoagulants and immunosuppressives. 相似文献
7.
Roxanne Parrott Marisa Greenberg Soo Jung Hong 《Journal of Applied Communication Research》2013,41(2):203-221
We explored the experiences and emotions women expressed about having a blood clot, including revelations about family members' decision to avoid disclosing inherited risk for clotting. We do this through analysis of in-depth life reflection interviews (N = 20) of women who experienced a first venous blood clot between the ages of 18 and 50 years. Selective coding reduced the data to an overarching story associated with thrombosis survivorship and loss across multiple life domains. The themes identified include participant revelations about living in the shadow of genetic susceptibility for thrombosis. Participants manage changes associated with lingering health effects, and daily routines for work and life, adapting their lives to manage coagulability. A second theme reveals the fallout linked to the severity of thrombosis encompassed in haunting psychological scenarios, persistent emotional concerns, and social discrimination. Participants assumed responsibility to disclose inherited risk, with the women expressing empowerment in knowing risks and acknowledging possible genetic testing mistakes. The overarching perspective was one of hope through proactive actions in occupational, recreational, and relational realms. We offer our findings as a theoretical depiction of thrombosis survivor identity and the need for public health and clinical communication to support disclosing family history for clotting. 相似文献
1